Skip to product information
1 of 1

GeneBio Systems

PE/Cyanine7 Anti-Mouse CD272/BTLA Antibody[PK18.6]

PE/Cyanine7 Anti-Mouse CD272/BTLA Antibody[PK18.6]

SKU:GBS-F1024UH

Regular price ¥68,600 JPY
Regular price Sale price ¥68,600 JPY
Sale Sold out
Shipping calculated at checkout.

Size:100μg

Storage:This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Flow Cytometry Antibodies

Abbreviation:CD272;BTLA

Target Synonym:B- and T-lymphocyte attenuator;B- and T-lymphocyte-associated protein;Btla;CD272

Research Areas:Immunology;Inhibitory Molecules

Conjugation:PE/Cyanine 7

Host:Rat

Species reactivity:Mouse

Application:FCM

Usage:Each lot of this antibody is quality control tested by flow cytometric analysis. Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. We suggest each investigator should titrate the reagent to obtain optimal results [The recommended concentration is 0.1-1 μg/106 cells in 100 μL volume].

Isotype:Rat IgG1, κ

Clonality:Monoclonal

Clone NO.:PK18.6

UNIProt ID:Q7TSA3

Background:CD272, also known as B and T lymphocyte attenuator (BTLA), is an Ig superfamily co-inhitory receptor with structural similarity to programmed cell death 1 (PD-1) and CTLA-4. BTLA is expressed on B cells, T cells, macrophages, dendritic cells, NKT cells, and NK cells. Engagement of BTLA by its ligand herpes virus entry mediator (HVEM) is critical for negatively regulating immune response. The absence of BTLA with HVEM inhibitory interactions leads to increased experimental autoimmune encephalomyelitis severity, enhanced rejection of partially mismatched allografts, an increased CD8+ memory T cell population, increased severity of colitis, and reduced effectiveness of T regulatory cells. BTLA plays an important role in the induction of peripheral tolerance of both CD4+ and CD8+ T cells in vivo. Tolerant T cells have significantly higher expression of BTLA compared with effectors and naïve T cells. BTLA may cooperate with CTLA-4 and PD-1 to control T cell tolerance and autoimmunity. It was reported that BTLA may regulate T cell function by binding to B7-H4, but further studies are needed to confirm. The existence of three distinct BTLA alleles has been reported.

Concentration:0.2 mg/mL

Control catalog number:E-AB-F09823H

Immunogen:

Buffer:Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.

Purification method:

Dilution:

GeneID:208154

View full details